Skip to main content
Top
Published in: International Urology and Nephrology 1/2012

01-02-2012 | Nephrology – Original Paper

Anemia at one year is an independent risk factor of graft survival

Authors: Luís Gustavo Modelli de Andrade, Juliana Maria Gera Abrão, Maria Fernanda Cordeiro Carvalho

Published in: International Urology and Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Post-transplant anemia is multifactorial and highly prevalent. Some studies have associated anemia with mortality and graft failure. The purpose of this study was to assess whether the presence of anemia at 1 year is an independent risk factor of mortality and graft survival.

Methods

All patients transplanted at a single center who survived at least 1 year after transplantation and showed no graft loss (n = 214) were included. Demographic and clinical data were collected at baseline and at 1 year. Patients were divided into two groups (anemic and nonanemic) based on the presence of anemia (hemoglobin < 130 g/l in men and 120 g/l in women).

Results

Baseline characteristics such as age, gender, type of donor, CKD etiology, rejection, and mismatches were similar in both groups. Creatinine clearance was similar in both anemic and nonanemic groups (69.32 ± 29.8 × 75.69 ± 30.5 ml/mim; P = 0.17). A Kaplan–Meier plot showed significantly poorer death-censored graft survival in the anemic group, P = 0.003. Multivariate analysis revealed that anemic patients had a hazard ratio for the graft loss of 3.85 (95% CI: 1.49–9.96; P = 0.005).

Conclusions

In this study, anemia at 1 year was independently associated with death-censored graft survival and anemic patients were 3.8-fold more likely to lose the graft.
Literature
1.
go back to reference Lorenz M, Kletzmayr J, Perschl A et al (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13(3):794–797PubMed Lorenz M, Kletzmayr J, Perschl A et al (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13(3):794–797PubMed
2.
go back to reference Molnar MZ, Novak M, Ambrus C et al (2005) Anemia in kidney transplanted patients. Clin Transplant 19(6):825–833PubMedCrossRef Molnar MZ, Novak M, Ambrus C et al (2005) Anemia in kidney transplanted patients. Clin Transplant 19(6):825–833PubMedCrossRef
3.
go back to reference Montanaro D (2007) Anemia after renal transplantation. G Ital Nefrol 24(1):13–22PubMed Montanaro D (2007) Anemia after renal transplantation. G Ital Nefrol 24(1):13–22PubMed
4.
go back to reference Fernandez FG, Palomar R, Rodrigo E et al (2005) Prevalence of anemia in renal transplant patients: results from MOST, an observational trial. Transplant Proc 37(9):3821–3822CrossRef Fernandez FG, Palomar R, Rodrigo E et al (2005) Prevalence of anemia in renal transplant patients: results from MOST, an observational trial. Transplant Proc 37(9):3821–3822CrossRef
5.
go back to reference Joist H, Brennan DC, Coyne DW (2006) Anemia in the kidney-transplant patient. Adv Chronic Kidney Dis 13(1):4–10PubMedCrossRef Joist H, Brennan DC, Coyne DW (2006) Anemia in the kidney-transplant patient. Adv Chronic Kidney Dis 13(1):4–10PubMedCrossRef
6.
go back to reference Rigatto C (2006) Anemia, renal transplantation, and the anemia paradox. Semin Nephrol 26(4):307–312PubMedCrossRef Rigatto C (2006) Anemia, renal transplantation, and the anemia paradox. Semin Nephrol 26(4):307–312PubMedCrossRef
7.
go back to reference Kadambi PV, Javaid B (2004) Cardiovascular diseases in kidney transplant recipients: the role of anemia. Adv Chronic Kidney Dis 11(3):328–333PubMedCrossRef Kadambi PV, Javaid B (2004) Cardiovascular diseases in kidney transplant recipients: the role of anemia. Adv Chronic Kidney Dis 11(3):328–333PubMedCrossRef
8.
go back to reference Winkelmayer WC, Lorenz M, Kramar R et al (2004) Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 4(12):2075–2081PubMedCrossRef Winkelmayer WC, Lorenz M, Kramar R et al (2004) Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 4(12):2075–2081PubMedCrossRef
9.
go back to reference Molnar MZ, Czira M, Ambrus C et al (2007) Anemia is associated with mortality in kidney-transplanted patients–a prospective cohort study. Am J Transplant 7(4):818–824PubMedCrossRef Molnar MZ, Czira M, Ambrus C et al (2007) Anemia is associated with mortality in kidney-transplanted patients–a prospective cohort study. Am J Transplant 7(4):818–824PubMedCrossRef
10.
go back to reference Silverberg DS, Wexler D, Iaina A et al (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26(4):296–306PubMedCrossRef Silverberg DS, Wexler D, Iaina A et al (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26(4):296–306PubMedCrossRef
11.
go back to reference Zalunardo N, Levin A (2006) Anemia and the heart in chronic kidney disease. Semin Nephrol 26(4):290–295PubMedCrossRef Zalunardo N, Levin A (2006) Anemia and the heart in chronic kidney disease. Semin Nephrol 26(4):290–295PubMedCrossRef
12.
go back to reference Nangaku M (2004) Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol 98(1):e8–e12PubMedCrossRef Nangaku M (2004) Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol 98(1):e8–e12PubMedCrossRef
13.
go back to reference Rossert J, Froissart M (2006) Role of anemia in progression of chronic kidney disease. Semin Nephrol 26(4):283–289PubMedCrossRef Rossert J, Froissart M (2006) Role of anemia in progression of chronic kidney disease. Semin Nephrol 26(4):283–289PubMedCrossRef
14.
go back to reference Kasiske BL, Vazquez MA, Harmon WE et al (2000) Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11(Suppl 15):S1–S86PubMed Kasiske BL, Vazquez MA, Harmon WE et al (2000) Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11(Suppl 15):S1–S86PubMed
15.
go back to reference Vanrenterghem Y, Ponticelli C, Morales JM et al (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3(7):835–845PubMedCrossRef Vanrenterghem Y, Ponticelli C, Morales JM et al (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3(7):835–845PubMedCrossRef
16.
go back to reference Vanrenterghem Y (2004) Anaemia after renal transplantation. Nephrol Dial Transplant 19(Suppl 5):V54–V58PubMedCrossRef Vanrenterghem Y (2004) Anaemia after renal transplantation. Nephrol Dial Transplant 19(Suppl 5):V54–V58PubMedCrossRef
17.
go back to reference Drueke TB, Locatelli F, Clyne N et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355(20):2071–2084PubMedCrossRef Drueke TB, Locatelli F, Clyne N et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355(20):2071–2084PubMedCrossRef
18.
go back to reference Gouva C, Nikolopoulos P, Ioannidis JP et al (2004) Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 66(2):753–760PubMedCrossRef Gouva C, Nikolopoulos P, Ioannidis JP et al (2004) Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 66(2):753–760PubMedCrossRef
Metadata
Title
Anemia at one year is an independent risk factor of graft survival
Authors
Luís Gustavo Modelli de Andrade
Juliana Maria Gera Abrão
Maria Fernanda Cordeiro Carvalho
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9854-0

Other articles of this Issue 1/2012

International Urology and Nephrology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.